Transcription of Full Prescribing Information - NERLYNX
{{id}} {{{paragraph}}}
HIGHLIGHTS OF Prescribing Information These highlights do not include all the Information needed to use NERLYNX safely and effectively. See full Prescribing Information for NERLYNX . NERLYNX (neratinib) tablets, for oral use Initial Approval: 2017 _____ INDICATIONS AND USAGE _____ NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy. (1, 14) _____ DOSAGE AND ADMINISTRATION _____ Antidiarrheal prophylaxis: Initiate loperamide with the first dose of NERLYNX and continue during first 2 cycles (56 days) of treatment. Instruct patients to maintain 1-2 bowel movements per day and on how to use antidiarrheal treatment regimens.
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE NERLYNX is indicated for the extended adjuvant treatment of adult patients with early stage
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}